(2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187-2200. http://doi.org/10.2147/copd.s378649.
(2022). Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax. http://doi.org/10.1136/thorax-2022-219642.
(2021). Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study. J Asthma Allergy, 14, 727-742. http://doi.org/10.2147/jaa.s306416.
(2017). Long-Acting beta-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2016.06.009.
(2017). Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study. Clin Epidemiol. http://doi.org/10.2147/clep.s127775.
(2017). Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2016.12.028.
(2018). Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022051.
(2018). Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population. Thorax. http://doi.org/10.1136/thoraxjnl-2017-210531.
(2018). Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. http://doi.org/10.2147/jaa.s176026.
(2018). Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study. NPJ Prim Care Respir Med. http://doi.org/10.1038/s41533-018-0095-5.